Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Probiotic suppositories is a live biotherapeutic product currently in preclinical development by the Institute of Virology, Vaccines and Sera "Torlak" (Torlak Institute) in Serbia. The product is designed for local administration, either rectally or vaginally, to deliver beneficial microorganisms intended to restore microbial balance and treat local dysbiosis or infections. As a preclinical asset, specific bacterial strains and primary clinical indications have not yet been disclosed by the developer, though such formulations are typically investigated for conditions like bacterial vaginosis or inflammatory bowel disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on probiotic suppositories.